WHWK
Whitehawk Therapeutics, Inc.
NASDAQ: WHWK · HEALTHCARE · BIOTECHNOLOGY
$4.04
-2.18% today
Updated 2026-04-29
Market cap
$194.92M
P/E ratio
—
P/S ratio
27.28x
EPS (TTM)
$-0.33
Dividend yield
—
52W range
$1 – $4
Volume
0.2M
Whitehawk Therapeutics, Inc. (WHWK) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-288.30%
Operating margin
-1,601.00%
ROE
-21.80%
ROA
-64.70%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $749000.00 | $-12.26M | -1,377.23% | -1,624.81% | -1,636.19% |
| 2020 | $14.58M | $-3.48M | -2.94% | -17.48% | -23.85% |
| 2021 | $1.12M | $-110.09M | -1,656.25% | -9,930.09% | -9,829.46% |
| 2022 | $15.22M | $-60.51M | -123.43% | -411.94% | -397.69% |
| 2023 | $24.35M | $-65.77M | -112.44% | -295.36% | -270.04% |
| 2024 | $25.98M | $-63.69M | -108.04% | -259.62% | -245.13% |
| 2025 | $7.14M | $-20.60M | 89.36% | -1,601.12% | -288.26% |